Emblok
Tampa, US · Founded 2025 · Delaware corporation · 1 known investors
Emblok develops the Emblok 360° whole body embolic protection system, a medical device used during left heart procedures such as TAVR to block and capture emboli and debris. It aims to reduce the risk of procedure-related strokes and damage to the heart, kidneys, and intestines for physicians and patients.
Founders & leadership
BB
Bradley BrownExecutive
CT
Charles TribieEVP, Manufacturing
Board
AJ
Alan J. SimonianBoard director
WM
William M. MerhiBoard director
Investors · 1
Reported raises · per SEC filings
Form D private placements$6M disclosed across 1 round · 2026
▶$6MraisedJun 2026 · 1 investors · BiotechnologyRule 506(b)
▶$6MraisedJun 2026 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Bradley BrownExecutive Officer
- William M. MerhiDirector
- Alan J. SimonianDirector
- Offering amount
- $12M
- Amount sold
- $6M
- First sale
- May 2026
- Incorporated
- Corporation, Delaware, 2025
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 5
by search overlapBoston Scientific7 shared keywordsBoston Scientific supports external researcher-initiated studies through its Investigator Sponsored Research program, which funds independent investigations addressing disease understanding and treatment gaps of interest to the medical community.
Rf Surgical7 shared keywordsMedtronic is a healthcare technology company that develops medical devices and technologies — including pacemakers, robotic-assisted surgery systems, and AI-driven health tools — used by doctors, scientists, and engineers to treat pain and disease. It works with clinicians to create solutions aimed at treating conditions such as AFib.
Emboline4 shared keywordsEmboline develops the Emboliner Embolic Protection System, a cerebral protection device aimed at preventing stroke during transcatheter aortic valve replacement (TAVR) procedures. The company serves interventional cardiologists in the structural heart and cardiovascular medical device market.
Bioworld3 shared keywordsBioWorld is a suite of daily news and data services covering therapeutics, medical technology, biopharma business transactions, and drug R&D, serving biopharmaceutical and medtech industry professionals. Owned by Clarivate, it publishes products including BioWorld, BioWorld Science, and BioWorld Asia with reporting from writers stationed globally.
Topera3 shared keywordsAbbott's Lingo Glucose System is a continuous glucose monitoring device for non-insulin users aged 18+, designed to track glucose levels and support metabolic health decisions.
Companies competing with Emblok for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Emblok has filed a notice of an exempt offering of securities to raise $12 Million in New Funding. - intelligence360intelligence360.news · Jul 2026Frequently asked questions
- What does Emblok do?
- Emblok develops the Emblok 360° whole body embolic protection system, a medical device used during left heart procedures such as TAVR to block and capture emboli and debris. It aims to reduce the risk of procedure-related strokes and damage to the heart, kidneys, and intestines for physicians and patients.
- Who are Emblok's investors?
- Emblok's investors include JStar Capital Investments.
- How much funding has Emblok raised?
- Emblok has disclosed $6M raised across 1 round.
- Where is Emblok headquartered?
- Emblok is headquartered in Tampa, US.